drugset / Trial / NCT03962296
A Multicenter, Randomized, Double-blind Non-inferiority Trial to Evaluate the Efficacy and Safety of Entelon®
RandomizedParallel-groupTriple-blindTreatment
Summary
This was a multicentre, randomised, double-blind controlled study that compared the efficacy and safety of V. vinifera extract, calcium dobesilate (CD), and placebo in subjects with DME. Patients made 6 clinic visits, namely the screening visit; baseline visit (T0); and follow-up visits at 3 (T3), 6 (T6), 9 (T9), and 12 (T12) months.
Timeline
- Start
- 2012-11-21
- Primary completion
- 2015-01-26
- Completion
- 2015-01-26
Publications
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Calcium Dobesilate | Unknown | 250 mg | Oral |
| Subject | Vitis vinifera extract | Unknown | 50 mg | Oral |